Glucose
- Generic Name
- Glucose
- Brand Names
- Bss Ophthalmic Solution, Citrasate, Clinimix 2.75/5, Clinimix E 2.75/5, Dextroject, Dianeal, H.E.L.P.bicel, Hemosate Ultra, Lactate 1-2-3, Leukotrap, Naturalyte, Nauzene, Normosol-R, Nxstage Pureflow, Olimel, Periolimel, Physioneal 40, Sag-M, Sclerodex, Selectbag One
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- IY9XDZ35W2
- Background
Glucose is a simple sugar (monosaccharide) generated during phosynthesis involving water, carbon and sunlight in plants. It is produced in humans via hepatic gluconeogenesis and breakdown of polymeric glucose forms (glycogenolysis). It circulates in human circulation as blood glucose and acts as an essential energy source for many organisms through aerobic o...
- Indication
Glucose pharmaceutical formulations (oral tablets, injections) are indicated for caloric supply and carbohydrate supplementation in case of nutrient deprivation. It is also used in metabolic disorders such as hypoglycemia.
- Associated Conditions
- Arrhythmia, Caloric Deficit, Edema of the cerebrum, Hypoglycemia, Metabolic Alkalosis
- Associated Therapies
- Blood Specimen Collection, Electrolyte replacement, Nutritional supplementation, Parenteral Nutrition, Parenteral rehydration therapy, Plasmapheresis, Positive cardiac inotropic effect, Total parenteral nutrition therapy, Urine alkalinization therapy, Fluid and electrolyte maintenance therapy
Liver Glycogen and Hypoglycemia in Humans
- Conditions
- Interventions
- First Posted Date
- 2017-08-07
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Jason Winnick
- Target Recruit Count
- 40
- Registration Number
- NCT03241706
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
Effects of Dextrose on Knee Osteoarthritis
- Conditions
- Interventions
- First Posted Date
- 2017-08-03
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- Taipei Medical University
- Target Recruit Count
- 106
- Registration Number
- NCT03238183
- Locations
- 🇨🇳
Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)
- Conditions
- Interventions
- First Posted Date
- 2017-03-29
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 33
- Registration Number
- NCT03095651
- Locations
- 🇺🇸
ProSciento Inc. ( Site 0001), Chula Vista, California, United States
40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose
- First Posted Date
- 2016-12-06
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- University of Targu Mures, Romania
- Target Recruit Count
- 200
- Registration Number
- NCT02984098
- Locations
- 🇷🇴
Department of Pediatrics, University of Medicine and Pharmacy Tirgu Mures, Tirgu Mures, Romania
Insulin Modulation of fMRI Connectivity in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2016-12-05
- Last Posted Date
- 2017-12-04
- Lead Sponsor
- University of Pittsburgh
- Registration Number
- NCT02982551
- Locations
- 🇺🇸
Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States
Multi-Center Study of Different Doses Domperidone in Feeding Intolerance
- Conditions
- Interventions
- First Posted Date
- 2016-12-02
- Last Posted Date
- 2017-09-15
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 118
- Registration Number
- NCT02980250
- Locations
- 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2016-09-22
- Last Posted Date
- 2022-04-25
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 44
- Registration Number
- NCT02910518
- Locations
- 🇩🇪
Investigational Site Number 276001, Neuss, Germany
Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 27
- Registration Number
- NCT02866435
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
A Single-dose Cross-over Study to Assess Direct and Indirect Effects of Dapagliflozin on Pancreatic Alpha and Beta Cells in Patients With Type 2 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2016-05-06
- Last Posted Date
- 2016-12-12
- Lead Sponsor
- Uppsala University
- Target Recruit Count
- 15
- Registration Number
- NCT02765204
- Locations
- 🇸🇪
Dept of Medical Sciences Uppsala University Hospital, Uppsala, Sweden
Polidocanol Versus Glucose Treatment of Telangiectasia Trial
- Conditions
- Interventions
- First Posted Date
- 2016-01-15
- Last Posted Date
- 2018-01-04
- Lead Sponsor
- UPECLIN HC FM Botucatu Unesp
- Target Recruit Count
- 115
- Registration Number
- NCT02657252
- Locations
- 🇧🇷
Vascular Lab, Botucatu, São Paulo, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.